THOMSON MEDICAL GROUP LIMITED
A50.SI : Singapore Exchange
0.057
0.00%
Share Price in SGD. As of 09:04:49 SGT
Summary
- 52-Week HighSGD 0.081
- 52-Week LowSGD 0.054
- Market CapSGD 1.5B
- Avg Volume2.8M
- P/E Ratio (TTM)Infinity
- Forward Dividend Yield0.70%
Consensus Share Price Target: No data available
No consensus on recommendation available. View analysis to learn more about THOMSON MEDICAL GROUP LIMITED.
Latest News
We're working on providing news on THOMSON MEDICAL GROUP LIMITED.
Performance
A50.SI | Market | |
---|---|---|
7 Day | -3.39% | 0.46% |
30 Day | -5.00% | -0.18% |
90 Day | -3.39% | 0.43% |
1 Year | -27.85% | -2.22% |
3 Year | 11.76% | 14.66% |
5 Year | -26.92% | 3.20% |
Include dividend return

See how much dividend you will receive in a year based on your investment amount
Dividend payout history
By SGX as of 26 Sep 2023
Ex-date | Payment date | Amount |
---|---|---|
2023 | Yield: 0.52% | Total: $0.0004 |
23/10/23 | 02/11/23 | $0.0004 |
2022 | Yield: 1.39% | Total: $0.00115 |
06/11/22 | 16/11/22 | $0.00115 |
2021 | Yield: 0.29% | Total: $0.00015 |
01/11/21 | 11/11/21 | $0.00015 |
Company Description
Listed on the Mainboard of the Singapore Exchange, Thomson Medical Group Limited (SGX: A50) is one of the leading listed healthcare players in the South-East Asian region with operations in Singapore and Malaysia.
Established in 1979, the Groupâs Thomson Medical Pte Ltd is one of the largest private provider of healthcare services for women and children in Singapore. It owns and operates the iconic Thomson Medical Centre and a network of specialist medical clinics and facilities providing outpatient women and children healthcare services and service offerings in diagnostic imaging, health screening, gynaecological oncology, dentistry, specialist dermatology, traditional Chinese medicine, musculoskeletal and sports medicine, and medical aesthetics.
The Group's operations in Malaysia under TMC Life Sciences Berhad is a multi-disciplinary healthcare company listed on Bursa Malaysia. It operates Thomson Hospital Kota Damansara, a tertiary hospital located in Kota Damansara, and the award-winning TMC Fertility Centre which is the industry leader in assisted reproduction in Malaysia. It also owns the proposed Thomson Iskandar Medical Hub, in Johor Bahru, Malaysia.
The Group also owns a prime 9.23 ha freehold waterfront land, strategically located in Johor Bahruâs City Centre, with a proposed long term plan to build an integrated healthcare city to meet the growing healthcare needs of the people in the region.